Issues
-
Cover Image
Cover Image
Somatic DNA mutations accumulate continuously in cells of multicellular organisms, and are passed on to the cells' progeny. Closely related cells tend to share more mutations, and cell lineage relationships can therefore be reconstructed from the degree of mutational similarity. Frumkin and colleagues isolated single cells from several foci of a mouse lymphoma and adjacent normal tissues by laser microdissection, and performed a phylogenetic-like analysis of mutations accumulated in the cells, resulting in a reconstructed cell lineage tree. Analysis of the tree reveals the monoclonal nature of the tumor (shaded sub-tree), its founder cell, its age, the physically coherent manner in which it grew, and the numbers of cell divisions leading to each cell (represented on the left as a vertical scale bar). The tumor is also associated with a specific mutation in p53 that was found in some of its cells (arrows). The approach described here can be useful for investigating basic properties of the growth and spread of early tumors, and the clonal dynamics that underlie cancer progression and metastasis formation. For details, see the article by Frumkin et al. on page 5924 of this issue.
- PDF Icon PDF LinkTable of Contents
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Reviews
Meeting Reports
XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from Molecular Pathogenesis to Targeted Therapy in Leukemia and Solid Tumors
Priority Reports
Novel MEK1 Mutation Identified by Mutational Analysis of Epidermal Growth Factor Receptor Signaling Pathway Genes in Lung Adenocarcinoma
Tissue-Specific Promoters Active in CD44+CD24−/low Breast Cancer Cells
Molecular Biology, Pathobiology, and Genetics
GSTP1 Promoter Haplotypes Affect DNA Methylation Levels and Promoter Activity in Breast Carcinomas
Genomic Alterations Indicate Tumor Origin and Varied Metastatic Potential of Disseminated Cells from Prostate Cancer Patients
Thymoquinone Triggers Inactivation of the Stress Response Pathway Sensor CHEK1 and Contributes to Apoptosis in Colorectal Cancer Cells
Cell, Tumor, and Stem Cell Biology
Cyclin D1b Is Aberrantly Regulated in Response to Therapeutic Challenge and Promotes Resistance to Estrogen Antagonists
The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-α Antitumor Effects
Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis
Tumor Microenvironment
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Systems Biology and Emerging Technologies
Immunology
Clinical Research
Epidemiology
Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms
Prevention
Corrections
Advertisement